MedTrace Logo

Neuroimaging Epigenetics of Prospective Postpartum Depression Biomarkers

NCT03638687 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2020-09-22

No results posted yet for this study

Summary

Through a recent cross species translational experiment, researchers have identified a set of epigenetic marks capable of predicting postpartum depression with greater than 85% accuracy. The researchers are looking to identify a group of women from both the general population and those with a history of mood disorders who are at risk for postpartum depression and obtain brain imaging data at a postpartum time period prior to the onset of depressive symptoms and compare it with those obtained during depressive episodes. The researchers will also evaluate the efficacy of postpartum depression biomarker prediction.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Zachary A Kaminsky, Ph.D. · Johns Hopkins University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2019-10-31
Completion
2020-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03638687 on ClinicalTrials.gov